Sfoglia per AUTORE
HAIOUN C
Collezione ASL Biella

  

Items : 2

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Thieblemont C; Zucca E; Luminari S; Bertoni F; Rossi D; Cavalli F; Pietrantuono G; Re F; Spina M; Landi F; Houot R; Merli M; Liberati AM; Haioun C; Cartron G; Devizzi L; Occhini U; Casasnovas RO; Califano C; Celli M; Pulsoni A; Angrilli F; Conconi A; Tessoulin B; Tilly H; Zanni M; Cabras MG; Capochiani E; Morschhauser F; et alii...

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.

2017
ASL Biella
AOU Città della Salute di Torino

Thieblemont C; Johnson P; Cavalli F; Mazzucchelli L; Campo E; Jack A; Moreau A; Ponzoni M; Bellei M; Stelitano C; Haioun C; Bosly A; Zachée P; Ferreri AJM; Hohaus S; Torri V; Tilly H; Morschhauser F; Devizzi L; Pinotti G; Guillermo AL; Sebban C; Salles G; Pettengell R; Martelli M; Vitolo U; Tucci A; Martinelli G; Bouabdallah R; et alii...